BioReperia

🌟 Curious about how our unique ZTX® platform works? 🤔 Click on the video link below and prepare to be amazed at how you, and the entire pharmaceutical industry, can benefit from this groundbreaking technology. 👇🎥 Would like to dive deeper into the details? Don't hesitate to reach out. We're here to answer your questions and explore the possibilities together! 🚀💬 📧 info@bioreperia.com 🌐 www.bioreperia.com #ZTXPlatform #PharmaInnovation #Bioreperia #UnlockingPotential #Zebrafish #Oncology #Clinicaldevelopment #Precisionmedicine #Healthcare #Drugdiscovery

🎉 Happy Holidays from the BioReperia Team! As 2024 comes to a close, we want to take a moment to thank you, our customers and partners, for your trust and collaboration throughout the year. While 2024 brought its share of challenges across many industries, it also presented us with opportunities to grow and innovate. At BioReperia, we reflect on our milestones and achievements with gratitude, knowing that each success was made possible by your continued support. As we look ahead to 2025, we remain dedicated to empowering your research and discoveries. Thank you for being part of our journey—we’re excited to continue growing together in the new year. Wishing you a joyful holiday season and a prosperous year ahead! Warm regards, The BioReperia Team #newyear2025 #collaboration #innovation #oncology #pharma #pharmaindustry #cancerresearch

🚨 BioReperia was present in New York! 🚨 Our team attended the Sixth International Prostate Cancer Symposium and the World Congress of Urologic Oncology 2024 at Mount Sinai, where we dived deep into the latest innovations in robotic surgery and cutting-edge patient treatment strategies. Our colleagues Anna Erkstam, Anna Fahlgren, and Gabriela Vazquez Rodriguez represented BioReperia at this incredible event! They learned invaluable insights that will help shape the future of prostate cancer care. From groundbreaking advancements in surgery to breakthrough therapies, this symposium was truly an eye-opening experience. We're thrilled to be part of the conversation and to contribute to the future of urologic oncology. A big thanks to Ash Tewari, MD, for organizing this amazing event and Sujit S. Nair and Dimple Chakravarty for the invitation 😁. #prostatecancer #conference #oncology #urology #precisionmedicine #cancerresearch #healthcare

✨ Thank You for Making the Webinar Series 2024 a Success! As we conclude our Webinar Series 2024, we extend our deepest gratitude to our esteemed guest speakers and collaborators who generously shared their expertise and enriched our discussions with invaluable insights: Linda Bojmar (Linköping University) Rispah Torrorey (Moi University) Joseph Bruckner, PhD (InVivo Biosystems) Sujit S. Nair (Icahn School of Medicine at Mount Sinai) Your contributions have shed light on how zebrafish models can address key challenges in cancer progression and metastasis research, accurately model human diseases, advance the development of innovative cancer therapies, and improve the prediction of patient treatment outcomes. We also want to thank all our attendees and everyone who participated in or supported this series. Your engagement inspires us, and we look forward to welcoming you to future events! For those who missed the live sessions or wish to revisit them, all recordings are now available on BioReperia's YouTube channel. Don’t miss this opportunity to explore these cutting-edge topics: ➡️ Zebrafish Tumor Xenograft Models: A Prognostic Approach to Epithelial Ovarian Cancer https://lnkd.in/dae63zRb ➡️ An In Vivo Zebrafish-Based Metastatic Model for Analyzing the Efficacy of Novel Anti-Cancer and Anti-Metastatic Compounds and Therapeutic Strategies https://lnkd.in/dc2PP-jN ➡️ Extracellular Vesicles in Cancer Research – New Opportunities Using ZTX Models https://lnkd.in/dUrUTzQh ➡️ Zebrafish Models for Breast Cancer Research – An Immunology Focus https://lnkd.in/dAJS5cpA ➡️ Advancing Human Disease Research with Zebrafish Models: From Tank to Bedside with Rapid In-Vivo Analysis https://lnkd.in/dPe7aaFQ ➡️ Advancing Prostate Cancer Targeted Therapy: Breakthroughs Using Zebrafish Tumor Xenograft Models https://lnkd.in/d72PTduC Happy watching, and thank you for being part of this incredible journey in advancing cancer research! #extracellularvesicles #prostatecancer #breastcancer #zebrafish #precisionmedicine #ovariancancer #metastasis #cancerresearch #webinar #drugdevelopment

Did you miss our recent collaborative webinar with Mount Sinai? No problem! The recorded session is now available on our YouTube channel 👉 https://lnkd.in/dxxXRPDW Discover how the zebrafish tumor xenograft model is advancing prostate cancer research by delivering highly translatable data on primary tumor size and metastasis—within just a few days. Looking to accelerate your prostate cancer research? Take advantage of our innovative platform and ongoing prostate cancer campaign. Contact us today at 📧 info@bioreperia.com to learn how we can support your work. #prostatecancer #drugdevelopment #pharmaindustry #zebrafish #cancerresearch #oncology

🌟 Grateful for Our Customers 🌟 A heartfelt thank you to Dave Taggart and the team at Glycyx for sharing this incredible testimonial. We’re so proud to have played a role in their journey, helping to lay the foundation for impactful advancements like preclinical programs and new patents. Collaborations like this inspire us every day to keep delivering innovative solutions. To David and the Glycyx team: we are deeply grateful for your trust in our #zebrafish model and us. Your success inspires us, and we look forward to supporting more groundbreaking achievements together in the future! #pharma #collaboration #cancerresearch #drugdevelopment

This month, we are happy to welcome Kristian Moller to the BioReperia team! 🎉 Kristian brings vast knowledge and expertise, with over 20 years of experience in biomarker discovery and developing different diagnostics assays. His impressive career spans contributions to cancer research/oncology and immunological disorders, with a focus on advancing R&D in the private pharma and biotech industries. We are truly excited to have Kristian on board and are confident he will bring exceptional value to our mission. Please join us in giving him a warm welcome to the BioReperia family! 🎇 #innovation #cancerresearch #pharma #biotech #oncology

🎬 DON'T MISS OUR LIVE WEBINAR TODAY! This unique live session will showcase new advancements in prostate cancer research and therapies derived from our collaboration with the Icahn School of Medicine at Mount Sinai and Pop Test Llc/Palisades Therapeutics at 4:30 PM CET / 10:30 AM EST. Register now 👉 https://lnkd.in/epRiVHZq #zebrafish #cancerresearch #prostatecancer #drugdevelopment #collaboration #pharma #oncology

The BioReperia team was present at the Nordic Zebrafish Meeting 2024 in Stockholm! 🐟✨ This incredible event brought together leading experts in #zebrafish husbandry and research. Our very own Michael Jury and Lasse Jensen took the stage, advocating for the zebrafish model as a transformative tool in #cancerresearch and #precisionmedicine. Their contributions included an insightful speech and a poster presentation showcasing how the zebrafish #tumor xenograft model can predict patient treatment outcomes. Mike perfectly captured the spirit of the conference: "A thoroughly interesting and thought-provoking conference. The range of studies that are using zebrafish, both adult and embryos, is quite incredible, from immunological to behavioral, but with a firm eye on welfare." A heartfelt thank you to Lars Braeutigam and the Karolinska Institutet team for organizing such an inspiring event. 🙌 #oncology #drugdevelopment #networking #healthcare

🌟 Exciting advancements in urology and robotic surgery are on the horizon! We’re glad to collaborate with the Icahn School of Medicine at Mount Sinai to drive innovation in #prostatecancer therapies. This partnership will be strengthened at the upcoming Sixth International Prostate Cancer Symposium and World Congress of Urologic Oncology, hosted at The Mount Sinai Hospital on December 11–14, 2024, where BioReperia will be present. 🌍✈️ Featuring over 80 world-renowned speakers, this global event will cover ground-breaking topics from basic science and artificial intelligence to live surgeries on prostate, kidney, and bladder cancer. Learn more at https://lnkd.in/eZ9xTFmh As part of this collaboration, BioReperia is proud to showcase our #zebrafish tumor xenograft platform in an exclusive co-hosted webinar with the Icahn School of Medicine at Mount Sinai this Wednesday, November 27th, at 10:30 AM EST / 4:30 PM CET. Dive into how our joint efforts are transforming prostate cancer research and therapies. 🎯 Don’t miss out on this webinar — reserve your spot today 👉 https://lnkd.in/dUY9EdcE https://lnkd.in/d3U-M-m8 https://lnkd.in/dd9SPwKz https://lnkd.in/d_HJi73C #cancerresearch #conference #partnership #collaboration #webinar #pharma #academia #drugdevelopment